SOME RISK FACTORS ASSOCIATED WITH MASKED HYPERTENSION IN DIABETES TYPE 2 PATENTS TREATED IN THAI BINH MEDICAL UNIVERSITY HOSPITAL IN 2020
Main Article Content
Abstract
Objective: To Identify risk factors associated with masked hypertension (MH) in diabetes type 2 patents treated in Thai Binh Medical University Hospital in 2020. Subjects and Methods: a cross-sectional study conducted from Jan - October 2020 in 186 diabetes type 2 patients treated in hospital of Thai Binh University of Medicine and Pharmacy. Results: by using APBM, 106 patients were detected having MH among 186 diabetes type 2 patients. Patients with BMI ≥ 23 were more likely having MH higher than patients with BMI > 23 (OR: 6.9; 95% CI: 3.4 – 14.2). MH were more likely to occur in patients who have family history of hypertension (OR = 5.5; 95% CI: 2.3 – 12.5). Patients with high normal clinic BP were more likely to diagnose of MH significantly (OR = 8.7; 95% CI: 4.4 – 17.5). Smoking and drinking patients have higher risk of MH (OR = 2.1; 95% CI: 1.1 – 4.0; OR = 2.0; 95% CI: 1.02 – 4.1, respectively). Patients with history of dyslipidemia have remarkably more risk of MH than normal patients (OR = 3.4; 95% CI: 1.8 – 6.3). Others possible risks of MH included: duration from diabetes diagnosed > 5 years; increasing uric acid. No significant statistical difference associated with MH found, related to gender, age, proteinuria level. Conclusion: possible risk of MH in diabetes patients included: BMI ≥ 23, having family history of hypertension, high normal clinic BP.
Article Details
Keywords
diabetes type 2, masked hypertension, MH
References
2. Nguyễn Trần Tuyết Trinh (2013), Khảo sát tình hình tăng huyết áp ẩn giấu ở bệnh nhân đái tháo đường týp 2, Luận văn bác sỹ nội trú, Trường Đại học Y Dược Thành Phố Hồ CHí Minh.
3. Wijkman M., Länne T., Engvall J. và cộng sự. (2009). Masked nocturnal hypertension a novel marker of risk in type 2 diabetes. Diabetologia, 52(7), 1258.
4. Nguyễn Văn Huấn (2014), Đặc điểm tăng huyết áp và một số yếu tố liên quan đến kết quả điều trị ở bệnh nhân đái tháo đường týp 2, Luận văn thạc sỹ, Đại học Y Dược Thái Nguyên.
5. Marchesi C, Maresca AM, và Solbiati F (2007). Masked hypertension in type 2 diabetes mellitus. American Journal of Hypertension, 20, 1079–1084.
6. Adler AI. và Stratton IM (2014). Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. British Medical Journal, 321, 412–419.
7. Thakkar H.V., Pope A., Anpalahan M. (2020). Masked Hypertension: A Systematic Review. Heart Lung Circulation, 29(1), 102–111.
8. Kario K., Park S., Chia Y.-C. et al (2020). Consensus summary on the management of hypertension in Asia from the HOPE Asia Network. Journal of Clinical Hypertens (Greenwich), 22(3), 351–362.